News alert: SquareX’s “Year of Browser Bugs” project exposes critical cybersecurity blind spots – Go Health Pro

News alert: SquareX’s “Year of Browser Bugs” project exposes critical cybersecurity blind spots – Go Health Pro

Palo Alto, Calif., Mar. 18, 2025, CyberNewswire — SquareX, a pioneer in Browser Detection and Response (BDR) space, announced the launch of the “Year of Browser Bugs” (YOBB) project today, a year-long initiative to draw attention to the lack of security research and rigor in what remains one of the most understudied attack vectors – … Read more

Will the Federal Reserve speed up US interest rate cuts this year? – Go Health Pro

Will the Federal Reserve speed up US interest rate cuts this year? – Go Health Pro

Investors will focus on the Federal Reserve’s outlook for the US economy when the central bank finishes its two-day meeting to set interest rates on Wednesday. Markets overwhelmingly expect borrowing costs to remain unchanged at between 4.25 and 4.5 per cent, based on futures markets prices. Instead investors will try to gauge chair Jay Powell’s … Read more

Zacks Small Cap Research – SDOT: Sadot Group Reports 2024 Financial Results Which Showed the First Full Year Positive Net Income in the Company’s History – Go Health Pro

By Thomas Kerr, CFA NASDAQ:SDOT READ THE FULL SDOT RESEARCH REPORT 4th Quarter and Full Year 2024 Financial Results On March 11, 2025, Sadot Group (NASDAQ:SDOT) reported 4th quarter and full year 2024 results which showed continued strength in the commodity trading business. In the latest filings, the restaurant operations have been reported as discontinued … Read more

Zacks Small Cap Research – MGRM: Monogram Technologies Reports 4th Quarter and Full Year 2024 Results – Go Health Pro

Zacks Small Cap Research – MGRM: Monogram Technologies Reports 4th Quarter and Full Year 2024 Results – Go Health Pro

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT 4th Quarter and Full Year 2024 Financial Results Monogram (NASDAQ:MGRM) reported 4th quarter and full year 2024 financial results on March 12th which were largely in line with our expectations. Research and development expenses for 2024 were $8.8 million compared to $10.6 million in … Read more

x